Zanubrutinib and Apixaban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Zanubrutinib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can raise your bleeding risk, so taking them together adds those risks up. Apixaban (Eliquis) is a blood thinner that stops clots from forming. Zanubrutinib (Brukinsa) treats certain cancers, and on its own it can also cause bleeding. When you combine them, the chance of bleeding, like easy bruising, nosebleeds, or bleeding that is harder to stop, can go up.
This does not mean you should stop either drug. Your care team chose this combination on purpose and will watch you closely. Just tell them right away about any unusual bruising, black or bloody stools, pink urine, or a bad headache. They can manage this safely.
Effect: Additive increase in bleeding risk with coadministration.
Mechanism: Pharmacodynamic (additive impairment of hemostasis). Apixaban is a direct factor Xa inhibitor; zanubrutinib (a BTK inhibitor) independently causes hemorrhage. This is a PD, not PK, interaction. Neither is a prodrug relevant here.
Evidence: Theoretical; severity rated major. Onset unspecified.
- Monitor closely for signs and symptoms of bleeding.
- Discontinue zanubrutinib for any grade of intracranial hemorrhage.
- Consider withholding zanubrutinib 3-7 days before and after surgery based on procedure and bleeding risk.
What happens
An increased risk of bleeding
Interaction Deep Dive
When zanubrutinib is given together with an anticoagulant, the likelihood of hemorrhage may rise further; bleeding has been reported both in patients receiving concurrent anticoagulation and in those who are not. Watch for signs and symptoms of bleeding. If intracranial hemorrhage of any grade develops, stop zanubrutinib. Weigh the benefits against the risks of holding zanubrutinib for 3-7 days both before and after a surgical procedure, taking into account the nature of the surgery and the bleeding risk involved1.
Why it happens (mechanism)
Additive effect on hemostasis
How to manage this interaction
The goal is to keep you on both medicines safely while watching closely for bleeding. Keep taking both exactly as prescribed unless your care team tells you otherwise.
- Watch for and report bleeding signs: unusual bruising, nosebleeds, bleeding gums, black or bloody stools, pink or red urine, coughing or vomiting blood, or a severe headache.
- Tell every provider you take both drugs, especially before any surgery or dental work, since they may pause zanubrutinib around a procedure (often 3-7 days before and after) depending on bleeding risk.
- Do not stop either drug on your own; let your prescriber adjust and individualize your plan.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Zanubrutinib and Apixaban together?
Combining apixaban and zanubrutinib adds up their bleeding risks, so keep taking both as prescribed but watch for bleeding and report it promptly, and remind your team before any surgery. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Zanubrutinib and Apixaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Zanubrutinib and Apixaban interaction managed?
The goal is to keep you on both medicines safely while watching closely for bleeding. Keep taking both exactly as prescribed unless your care team tells you otherwise. Watch for and report bleeding signs: unusual bruising, nosebleeds, bleeding gums, black or bloody stools, pink or red urine, coughing or vomiting blood, or a severe headache. Tell every provider you take both drugs, especially befor… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Zanubrutinib or Apixaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BRUKINSA(R) oral capsules, oral tablets, zanubrutinib oral capsules, oral tablets. BeOne Medicines USA, Inc. (per FDA), Pennington, NJ, 2025. DailyMed
Keep reading about Apixaban
Keep reading about Zanubrutinib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist